Aimwell Partners Inc. (OTC: AIMN) Opens No-Cost Observer Access and Publishes The Standard Behind Its Verified Intelligence Platform

Credentialed biopharma professionals can now access AimwellBio's Observer tier at no cost, while the company publishes the Adversarial Validation Standard, v1-the methodology behind every verified intelligence output. MIAMI, FL / ACCESS Newswire / …